Abercrombie & Fitch Co (ANF) stock
Close on Nov 17, 2026Market cap $6.06BP/E 12.2Yield –
Earnings
Abercrombie & Fitch's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Abercrombie & Fitch's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Nov 1, 2026 | Nov 25, 2026Expected | – | – | – | – | – |
| Q2 FY2026ended Aug 1, 2026 | Aug 26, 2026before the open | $1.30B | +8.3% | $4.17 | – | Release |
| Q1 FY2026ended May 2, 2026 | May 27, 2026before the open | $1.10B | 0.0% | $1.47 | $1.47 | Release |
| Q4 FY2025ended Jan 31, 2026 | Mar 4, 2026before the open | $1.67B | +5.7% | $3.68 | $3.68 | Release |
| Q3 FY2025ended Nov 1, 2025 | Nov 26, 2025during market hours | $1.29B | +7.6% | $2.36 | $2.36 | Release |
| Q2 FY2025ended Aug 2, 2025 | Aug 28, 2025during market hours | $1.20B | +9.1% | $2.91 | $2.32 | Release |
| Q1 FY2025ended May 3, 2025 | May 29, 2025during market hours | $1.10B | +10.0% | – | – | Release |
| Q4 FY2024ended Feb 1, 2025 | Mar 6, 2025during market hours | $1.58B | +5.3% | $3.57 | – | Release |
| Q3 FY2024ended Nov 2, 2024 | Nov 27, 2024during market hours | $1.20B | +9.1% | $2.50 | $2.50 | Release |
| Q2 FY2024ended Aug 3, 2024 | Aug 29, 2024during market hours | $1.10B | +17.6% | $2.50 | $2.50 | Release |
| Q1 FY2024ended May 4, 2024 | May 30, 2024during market hours | $1.00B | +19.6% | $2.14 | $2.14 | Release |
| Q4 FY2023ended Feb 3, 2024 | Mar 7, 2024during market hours | $1.50B | +25.0% | $2.97 | $2.97 | Release |
| Q3 FY2023ended Oct 28, 2023 | Nov 22, 2023during market hours | $1.10B | +25.0% | $1.83 | $1.83 | Release |
| Q2 FY2023ended Jul 29, 2023 | Aug 24, 2023during market hours | $935.00M | +16.1% | $1.10 | $1.10 | Release |
| Q1 FY2023ended Apr 29, 2023 | May 25, 2023during market hours | $836.00M | +2.8% | $0.32 | $0.39 | Release |
| Q4 FY2022ended Jan 28, 2023 | Mar 2, 2023during market hours | $1.20B | 0.0% | $0.75 | $0.81 | Release |
| Q3 FY2022ended Oct 29, 2022 | Nov 23, 2022during market hours | $880.00M | -2.8% | -$0.04 | $0.01 | Release |
| Q2 FY2022ended Jul 30, 2022 | Aug 29, 2022during market hours | $805.00M | – | -$0.33 | -$0.30 | Release |
| Q1 FY2022ended Apr 30, 2022 | May 25, 2022during market hours | $813.00M | – | -$0.32 | -$0.27 | Release |
| Q4 FY2021ended Jan 29, 2022 | Mar 3, 2022during market hours | $1.20B | – | $1.12 | $1.14 | Release |
| Q3 FY2021ended Oct 30, 2021 | Nov 24, 2021during market hours | $905.00M | – | $0.77 | $0.86 | Release |
| Q2 FY2021ended Jul 31, 2021 | Aug 27, 2021during market hours | – | – | – | – | Filing |
| Q1 FY2021ended May 1, 2021 | May 27, 2021during market hours | – | – | – | – | Filing |
| Q4 FY2020ended Jan 30, 2021 | Mar 3, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Oct 31, 2020 | Nov 25, 2020during market hours | – | – | – | – | Filing |
| Q2 FY2020ended Aug 1, 2020 | Aug 28, 2020during market hours | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Abercrombie & Fitch's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net sales | FY2026 | +3% – +5% | +3% – +5% | Reaffirmed | May 27, 2026 |
| Operating margin | FY2026 | 12% – 12.5% | 12% – 12.5% | Reaffirmed | May 27, 2026 |
| Net income per diluted share | FY2026 | $10.20 – $11.00 | $10.20 – $11.00 | Reaffirmed | May 27, 2026 |
| Capital expenditures | FY2026 | $225.00M | $200.00M – $225.00M | Raised | May 27, 2026 |
| Diluted weighted average shares | FY2026 | 45 | – | New | Mar 4, 2026 |
| Effective tax rate | FY2026 | 29% | – | New | Mar 4, 2026 |
| Share repurchases | FY2026 | $450.00M | – | New | Mar 4, 2026 |
Guidance vs results
The last range Abercrombie & Fitch gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2026 | EPS (GAAP) | $1.80 – $2.00 | $4.17 | Above range |
| Q2 FY2026 | Revenue growth | +2% – +4% | +8.33% | Above range |
| Q1 FY2026 | EPS (GAAP) | $1.20 – $1.30 | $1.47 | Above range |
| Q1 FY2026 | Revenue growth | +1% – +3% | 0% | Below range |
| FY2025 | Revenue growth | +6% – +7% | +7.8%Σ4Q | Above range |
| Q4 FY2025 | EPS (GAAP) | $3.40 – $3.70 | $3.68 | Within range |
| Q4 FY2025 | Revenue growth | +4% – +6% | +5.7% | Within range |
| Q3 FY2025 | EPS (GAAP) | $2.05 – $2.25 | $2.36 | Above range |
| Q3 FY2025 | Revenue growth | +5% – +7% | +7.55% | Above range |
| Q4 FY2024 | Revenue growth | +5% – +7% | +5.33% | Within range |
| Q2 FY2023 | Revenue growth | +4% – +6% | +16.15% | Above range |
| Q1 FY2023 | Revenue | $813.00M | $836.00M | Above range |
| Q4 FY2022 | Revenue growth | -4% – -2% | 0% | Above range |
Guidance history
Every forecast Abercrombie & Fitch put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| May 27, 2026 | Capital expenditures | FY2026 | $225.00M | Raised |
| May 27, 2026 | Net income per diluted share | FY2026 | $10.20 – $11.00 | Reaffirmed |
| May 27, 2026 | Net income per diluted share | Q2 FY2026 | $1.80 – $2.00 | New |
| May 27, 2026 | Operating margin | Q2 FY2026 | 10% | New |
| May 27, 2026 | Operating margin | FY2026 | 12% – 12.5% | Reaffirmed |
| May 27, 2026 | Net sales | Q2 FY2026 | +2% – +4% | New |
| May 27, 2026 | Net sales | FY2026 | +3% – +5% | Reaffirmed |
| Mar 4, 2026 | Capital expenditures | FY2026 | $200.00M – $225.00M | New |
| Mar 4, 2026 | Net income per diluted share | Q1 FY2026 | $1.20 – $1.30 | New |
| Mar 4, 2026 | Net income per diluted share | FY2026 | $10.20 – $11.00 | New |
| Mar 4, 2026 | Operating margin | Q1 FY2026 | 7% | New |
| Mar 4, 2026 | Operating margin | FY2026 | 12% – 12.5% | New |
| Mar 4, 2026 | Share repurchases | FY2026 | $450.00M | New |
| Mar 4, 2026 | Effective tax rate | FY2026 | 29% | New |
| Mar 4, 2026 | Effective tax rate | Q1 FY2026 | 26% | New |
| Mar 4, 2026 | Share repurchases | Q1 FY2026 | $100.00M | New |
| Mar 4, 2026 | Diluted weighted average shares | FY2026 | 45 | New |
| Mar 4, 2026 | Diluted weighted average shares | Q1 FY2026 | 46 | New |
| Mar 4, 2026 | Net sales | FY2026 | +3% – +5% | New |
| Mar 4, 2026 | Net sales | Q1 FY2026 | +1% – +3% | New |
| Nov 26, 2025 | Capital expenditures | FY2025 | $225.00M | New |
| Nov 26, 2025 | Net income per diluted share | Q4 FY2025 | $3.40 – $3.70 | New |
| Nov 26, 2025 | Net income per diluted share | FY2025 | $10.20 – $10.50 | New |
| Nov 26, 2025 | Operating margin | FY2025 | 13% – 13.5% | New |
| Nov 26, 2025 | Operating margin | Q4 FY2025 | 14% | New |
| Nov 26, 2025 | Share repurchases | Q4 FY2025 | $100.00M | New |
| Nov 26, 2025 | Diluted weighted average shares | Q4 FY2025 | 47 | New |
| Nov 26, 2025 | Effective tax rate | Q4 FY2025 | 30% | New |
| Nov 26, 2025 | Diluted weighted average shares | FY2025 | 48 | New |
| Nov 26, 2025 | Effective tax rate | FY2025 | 30% | New |
| Nov 26, 2025 | Share repurchases | FY2025 | $450.00M | New |
| Nov 26, 2025 | Net sales | FY2025 | +6% – +7% | New |
| Nov 26, 2025 | Net sales | Q4 FY2025 | +4% – +6% | New |
| Aug 28, 2025 | Capital expenditures | FY2025 | $225.00M | New |
| Aug 28, 2025 | Net income per diluted share | Q3 FY2025 | $2.05 – $2.25 | New |
| Aug 28, 2025 | Net income per diluted share | FY2025 | $10.00 – $10.50 | Lowered |
| Aug 28, 2025 | Operating margin | Q3 FY2025 | 11% – 12% | New |
| Aug 28, 2025 | Operating margin | FY2025 | 13% – 13.5% | Lowered |
| Aug 28, 2025 | Share repurchases | FY2025 | $400.00M | Reaffirmed |
| Aug 28, 2025 | Diluted weighted average shares | FY2025 | 49 | Lowered |
| Aug 28, 2025 | Effective tax rate | FY2025 | 30% | Raised |
| Aug 28, 2025 | Diluted weighted average shares | Q3 FY2025 | 48 | New |
| Aug 28, 2025 | Effective tax rate | Q3 FY2025 | 31% | New |
| Aug 28, 2025 | Share repurchases | Q3 FY2025 | $50.00M | New |
| Aug 28, 2025 | Net sales | Q3 FY2025 | +5% – +7% | New |
| Aug 28, 2025 | Net sales | FY2025 | +5% – +7% | Raised |
| Mar 6, 2025 | Net income per diluted share (3) (4) | FY2025 | $10.40 – $11.40 | New |
| Mar 6, 2025 | Operating margin (1) | FY2025 | 14% – 15% | New |
| Mar 6, 2025 | Effective tax rate (2) | FY2025 | 26% | New |
| Mar 6, 2025 | Diluted weighted average shares (3) | FY2025 | 51 | New |
| Mar 6, 2025 | Share repurchases (4) | FY2025 | $400.00M | New |
| Mar 6, 2025 | Net sales | FY2025 | +3% – +5% | New |
| Nov 27, 2024 | Capital expenditures | FY2024 | $170.00M | Reaffirmed |
| Nov 27, 2024 | Operating margin | FY2024 | 15% | Raised |
| Nov 27, 2024 | Net sales | Q4 FY2024 | +5% – +7% | New |
| Aug 29, 2024 | Capital expenditures | FY2024 | $170.00M | Reaffirmed |
| Aug 29, 2024 | Operating margin | FY2024 | 14% – 15% | Raised |
| Aug 29, 2024 | Operating margin | Q3 FY2024 | 13% – 14% | New |
| Aug 29, 2024 | Net sales growth | FY2024 | +12% – +13% | Raised |
| May 30, 2024 | Capital expenditures | FY2024 | $170.00M | Reaffirmed |
| May 30, 2024 | Operating margin | Q2 FY2024 | 13% – 14% | New |
| May 30, 2024 | Operating margin | FY2024 | 14% | Raised |
| May 30, 2024 | Net sales | FY2024 | +10% | Raised |
| Mar 7, 2024 | Capital expenditures | FY2024 | $170.00M | New |
| Mar 7, 2024 | Operating margin | Q1 FY2024 | 8% – 10% | New |
| Mar 7, 2024 | Operating margin | FY2024 | 12% | New |
| Mar 7, 2024 | Effective tax rate | Q1 FY2024 | 10% | New |
| Mar 7, 2024 | Net sales growth | FY2024 | +4% – +6% | New |
| Nov 22, 2023 | Capital expenditures | FY2023 | $160.00M | Reaffirmed |
| Nov 22, 2023 | Operating margin | Q4 FY2023 | 12% – 14% | New |
| Nov 22, 2023 | Operating margin | FY2023 | 10% | Raised |
| Nov 22, 2023 | Effective tax rate | Q4 FY2023 | 30% | New |
| Nov 22, 2023 | Net sales growth | FY2023 | +12% – +14% | Raised |
| Aug 24, 2023 | Capital expenditures | FY2023 | $160.00M | Reaffirmed |
| Aug 24, 2023 | Operating margin | FY2023 | 8% – 9% | Raised |
| Aug 24, 2023 | Operating margin | Q3 FY2023 | 8% – 10% | New |
| Aug 24, 2023 | Net sales growth | FY2023 | +10% | Raised |
| May 25, 2023 | Capital expenditures | FY2023 | $160.00M | Reaffirmed |
| May 25, 2023 | Operating margin | Q2 FY2023 | 2% – 3% | New |
| May 25, 2023 | Operating margin | FY2023 | 5% – 6% | Raised |
| May 25, 2023 | Effective tax rate | Q2 FY2023 | 50% | New |
| May 25, 2023 | Net sales growth | FY2023 | +2% – +4% | Raised |
| May 25, 2023 | Net sales growth | Q2 FY2023 | +4% – +6% | New |
| Mar 2, 2023 | Capital expenditures | FY2023 | $160.00M | New |
| Mar 2, 2023 | Operating margin | FY2023 | 4% – 5% | New |
| Mar 2, 2023 | Net sales | Q1 FY2023 | $813.00M | New |
| Mar 2, 2023 | Net sales growth | FY2023 | +1% – +3% | New |
| Nov 23, 2022 | Capital expenditures | FY2022 | $170.00M | Raised |
| Nov 23, 2022 | Operating margin | Q4 FY2022 | 5% – 7% | New |
| Nov 23, 2022 | Operating margin | FY2022 | 2% – 3% | Raised |
| Nov 23, 2022 | Net sales | FY2022 | -3% – -2% | Lowered |
| Nov 23, 2022 | Net sales | Q4 FY2022 | -4% – -2% | New |
| Aug 29, 2022 | Capital expenditures | FY2022 | $150.00M | Reaffirmed |
| Aug 29, 2022 | Operating margin | FY2022 | 1% – 3% | Lowered |
| May 25, 2022 | Capital expenditures | FY2022 | $150.00M | Reaffirmed |
| May 25, 2022 | Operating margin | Q2 FY2022 | 3% – 4% | New |
| May 25, 2022 | Operating margin | FY2022 | 5% – 6% | New |
| Mar 3, 2022 | Capital expenditures | FY2022 | $150.00M | New |
| Mar 3, 2022 | Operating expense, excluding other operating income | Q1 FY2022 | +6% | New |
| Mar 3, 2022 | Operating expense, excluding other operating income | FY2022 | +2% – +4% | New |
| Mar 3, 2022 | Net sales | FY2022 | +2% – +4% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Abercrombie & Fitch filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?